Federal Appeals Court Judges Press Nexstar About Its Quest To Narrow Tegna Merger Order
A federal appeals court is reviewing Nexstar's request to narrow a merger order with Tegna. Attorneys for DirecTV and states argued against focusing on 31 stations, stating a full unwinding would restore competition. Nexstar's stock has slipped 10% during the legal process. The court will decide in early 2027, with a jury trial set for July 2027.
How this was made

The 30-second read
Why it matters
The key trading variable is the scope of any required unwinding or remedy. A ruling against Nexstar could increase disruption risk and delay post-merger integration, while a narrower remedy could reduce operational and valuation uncertainty.
Market read
Appellate judges are actively scrutinizing the remedy scope for the Nexstar-Tegna merger, with a decision expected in early 2027 and a jury trial scheduled for next July.
What to watch
The article notes a scheduled jury trial next July and possible procedural outcomes (remand, en banc, Supreme Court), which can extend uncertainty beyond the early-2027 decision window.
Background
The piece describes oral arguments in a federal appeals court over how to narrow an injunction/TRO related to the Nexstar-Tegna merger, including debate over whether only 31 stations should be carved out versus a full unwinding.
Ticker impact
Nexstar is the defendant in the Nexstar-Tegna merger antitrust case, with judges pressing it on how to narrow the merger order.
Likely volatility and downside risk if the panel rejects Nexstar’s proposed narrowing approach.
The article highlights ongoing appellate deliberation, potential remand, and a possible adverse ruling that could force broader unwinding than Nexstar prefers.
Market effects
Reinforces regulatory and litigation risk for broadcast-media consolidation, potentially raising deal-friction expectations across the sector.
Primarily US-focused legal process affecting US broadcast station ownership structures.
Limited direct global spillover, but it can influence cross-border investor sentiment toward US media M&A risk.
Counterpoint
Even if the panel narrows the order, the market may price a partial remedy as sufficient to preserve competitive harm, reducing tail risk for the deal economics.
Key entities
- companyNexstar Media Group
Defendant in the Nexstar-Tegna merger antitrust case; argues against carving out only 31 stations.
- companyTegna
Target of the merger challenged in court; remedy scope affects competitive restoration and deal disruption risk.
- companyDirecTV
Named in the oral arguments as a party presenting its position.
- governmentCalifornia Department of Justice
Argues that focusing on 31 stations is not coherent and supports evidence for full unwinding.



